Market Cap (In SEK)
284.91 Million
Revenue (In SEK)
2.01 Million
Net Income (In SEK)
5.38 Million
Avg. Volume
242.37 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.95-1.9
- PE
- -
- EPS
- -
- Beta Value
- 0.194
- ISIN
- SE0002190926
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Viktor Drvota M.D., Ph.D.
- Employee Count
- -
- Website
- https://www.karolinskadevelopment.com
- Ipo Date
- 2011-04-15
- Details
- Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
More Stocks
-
UDCD
-
SURI
-
MTSI
-
RHL
-
YATHARTH
-
BHARATWIREBharat Wire Ropes Limited
BHARATWIRE
-
HINDCOPPERHindustan Copper Limited
HINDCOPPER
-
TRAC